About

Mahsoem Ali is a leading surgical researcher whose work centers on advancing minimally invasive techniques for pancreatic surgery, with a particular focus on improving outcomes for patients with pancreatic neoplasms and cancer. His major contributions include landmark comparative studies that evaluate the safety, efficacy, and long-term survival of minimally invasive versus open pancreatoduodenectomy and left pancreatectomy. Notably, his 2025 paper on minimally invasive versus open pancreatoduodenectomy, with 20 citations, addresses the critical debate over whether the minimally invasive approach can accelerate recovery without compromising safety. Ali also co-authored the DIPLOMA trial follow-up, which provides essential data on long-term overall and disease-free survival after minimally invasive left pancreatectomy. His work on predicting postoperative pancreatic fistula after robotic pancreatoduodenectomy, using validated risk scores, has practical implications for reducing morbidity and mortality. Additionally, Ali has contributed to health economics by analyzing the cost implications of implementing robot-assisted pancreatoduodenectomy, offering insights for high-volume centers weighing clinical benefits against financial burdens. His research is instrumental in shaping evidence-based guidelines for pancreatic surgery.

Research Focus

Key Achievements

3
H-Index
4
Papers
37
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms
20 citations · 2025
📈 Most Prolific Year: 2025 (4 Papers)
🤝 Key Collaborators: 79
🏛 Institutions: Cancer Center Amsterdam, Fondazione Poliambulanza Istituto Ospedaliero, Amsterdam University Medical Centers

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago